Hercules Capital

Hercules is the largest non-bank lender to venture capital-backed companies at all stages of development in a broadly diversified variety of technology, life sciences, and sustainable and renewable technology industries. With over a decade of experience in venture debt, Hercules is uniquely positioned to quickly create innovative financing solutions that perfectly fit within a company's existing capital structure and map to its business objectives. Recognized as the industry leader, Hercules understands the flexibility these types of companies need and has the experience to work closely with them, even through challenging times, to help them reach critical milestones. Hercules' deep sector expertise, geographic presence and its strong capital base have made Hercules the lender of choice for more than 480 innovative companies.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Hercules Capital achieves record performance in 2022, eyes growth opportunities

Hercules Capital's 2022 performance was exceptional, marked by record results and strong credit quality. The company's focus for 2023 includes maintaining a strong balance sheet, disciplined underwriting, and strategic investments. Anticipate increased VC investment activity and an uptick in M&A transactions in the coming year.

Hercules Capital excels in Q1 2023, eyes strategic partnerships

Hercules Capital's Q1 2023 showcased resilience and growth, with strong financial metrics and strategic initiatives. Despite market challenges, the company maintained credit quality and liquidity while exploring opportunities for expansion and partnership enhancement.

Hercules Capital (HTGC) reports record Q2 results and eyes market growth opportunities

Hercules Capital delivered strong Q2 results with record investment income and robust credit quality, showcasing expertise in deal selection and industry diversification.
While facing challenges in meeting earnings expectations and providing detailed diversification insights, the company's strong liquidity and market positioning offer opportunities for future growth and strategic investments.
Overall, Hercules Capital's performance highlights resilience in a dynamic market environment, emphasizing its potential for sustained growth and value creation for investors.

Hercules Capital (HTGC) reports record Q3 earnings and strategic growth

Hercules Capital (HTGC) delivered exceptional financial results in Q3 2023, marked by record earnings and prudent portfolio management.
The company's strategic focus on credit quality, portfolio diversification, and liquidity positions it well for future growth and investment opportunities.
Despite challenges such as asset valuation fluctuations, Hercules Capital remains resilient and poised to capitalize on market dynamics for sustained success.

Hercules Capital reports record Q4 performance and eyes growth opportunities

Hercules Capital (HTGC) delivered strong financial performance in Q4 2023, emphasizing quality, diversification, and growth in key sectors like life sciences.
While challenges exist in managing expenses and optimizing capital efficiency, the company's conservative approach and liquidity position provide a solid foundation for future success.
Opportunities lie in expanding the venture and growth stage asset class, driving platform growth, and engaging with investors at upcoming conferences.

Hercules Capital excels in Q1 2024, poised for strategic growth

Hercules Capital delivered exceptional performance in Q1 2024, with record origination and funding, strong investment income, improved credit quality, and robust liquidity, positioning the company for continued success.
The company's strengths lie in its solid balance sheet, under-levered position, focus on quality growth, and favorable standing with rating agencies, providing a strong foundation for future growth.
Challenges include managing leverage increase, debt refinancing, maintaining credit quality standards, and navigating market uncertainties, requiring strategic planning and risk management.
Opportunities for Hercules include leveraging its milestone anniversary, expanding investor base through conferences, exploring new investments, and driving sustainable growth through prudent strategies.

Hercules Capital posts record Q2 results amidst market volatility

Hercules Capital delivered a strong performance in Q2 2024, marked by record fundings and asset growth, despite anticipating increased market volatility ahead.
The company's focus on credit quality, liquidity, and diversification through SBIC licenses strengthens their resilience and growth prospects.
While facing challenges such as market volatility and prepayment expectations, Hercules Capital remains well-positioned to leverage opportunities and navigate uncertainties.

Hercules Capital (HTGC) reports record Q3 earnings amidst market challenges

Hercules Capital (HTGC) reported strong financial performance in Q3 with record total investment income and NII, despite challenges in the venture capital ecosystem.
Maintaining a defensive balance sheet approach and strong liquidity, Hercules is well-positioned to navigate market uncertainties and capitalize on growth opportunities.
While facing challenges from market slowdowns, Hercules' prudent underwriting and commitment to shareholder returns showcase resilience and long-term stability.
With opportunities arising from increased funding activity post-Fed rate action and pending commitments, Hercules is poised for potential growth in Q4 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hercules Capital, Inc. is a specialty finance company, which focuses on providing senior secured loans to high-growth, innovative venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. The company was founded by Manuel A. Henriquez in December 2003 and is headquartered in Palo Alto, CA.

Hercules Capital, Inc. (HTGC) CEO Scott Bluestein on Q3 2021 Results - Earnings Call Transcript

Hercules Tech (HTGC) delivered earnings and revenue surprises of 3.13% and -1.89%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Hercules Technology (HTGC) Tops Q3 Earnings Estimates

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended September 30, 2021. “Hercules' leadership position, scale and brand reputation as the largest nonbank provider of venture a

Hercules Capital Reports Third Quarter 2021 Financial Results

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a supplemental cash distribution of $0.07 per share. This supplemental cash distribution will be paid out of Hercules Capital

Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declared a third quarter 2021 cash distribution of $0.33 per share. The following shows the key dates of the third quarte

Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021

Hercules Tech (HTGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Hercules Technology (HTGC) Q3 Earnings Expected to Decline

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Pam Randhawa was appointed to serve as a member of its board of directors, effective November 1, 2021. Ms. Randhawa is a thought leader within the life sciences sector

Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors

Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities

Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2021 financial results conference call for Thursday, October 28, 2021, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its fina

Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference Call

Hercules Capital is a tech and life sciences focused BDC, with a strong track record of shareholder returns. It carries a higher investment yield than most BDCs, and is seeing a very favorable demand environment.

Hercules Capital: Stash Cash With This Retirement Income Opportunity

BOSTON, Sept. 27, 2021 /PRNewswire/ -- Corium, Inc. (Corium), a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, today announces that it has closed on a $235 million term loan agreement with Hercules Capital, Inc. (NYSE: HTGC), a leader in specialty financing for life science and technology companies.

Corium Secures $235 Million in Debt Financing

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with external funds managed by its adviser subsidiary, have originated more than $1.5 billion year-to-date in annual total gross debt and equity commitment

Hercules Capital Delivers a New Record by Surpassing $1.5 Billion of Annual Gross Debt and Equity Commitments

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due 2026 (the “Notes”). The Notes are unsecured and bear interest at a rate of 2.625% per year, payable semiannually and will mature on September 16, 2026 and may be redeemed in whole or in part at any time or from time to time at the Company's option at par, plus

Hercules Capital Closes Public Offering of $325.0 Million 2.625% Notes due 2026

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due September 2026 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on September 16, 2021. The Notes are unsecured and bear interest at a rate of 2.625% per year, payabl

Hercules Capital Prices Public Offering of $325.0 Million 2.625% Notes Due 2026

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it has secured a loan facility for up to $50 million from Hercules Capital, Inc. (NYSE: HTGC). “This transaction comes on the heels of an eventful few months, including the announcement of our pending SPAC merger and concurrent PIPE financing, as well as the i

Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has originated more than $1.0 billion year-to-date in annual total debt and equity commitments for the fourth consecutive year. “We could not be more pleased to achi

Hercules Capital Reaches $1.0 Billion Milestone in Annual Debt and Equity Commitments for the Fourth Consecutive Year

HTGC yields 8.97%, including its supplemental quarterly distributions. Mgt. declared a $.32 regular and a $.07 supplemental quarterly distribution for August.

Hercules Capital: 9% Yielding Venture Capital BDC

Hercules Capital (HTGC) records a rise in total investment income and expenses in the second quarter of 2021.

Hercules Capital (HTGC) Q2 Earnings Meet Estimates, Costs Rise

Hercules Tech (HTGC) delivered earnings and revenue surprises of 0.00% and -0.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Hercules Technology (HTGC) Q2 Earnings Meet Estimates

Hercules Capital, Inc. (HTGC) CEO Scott Bluestein on Q2 2021 Results - Earnings Call Transcript

Shares of Hercules Cap (NYSE:HTGC) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to $0.32, which were in line with the estimate of $0.32.

Recap: Hercules Cap Q2 Earnings

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30, 2021. “During Q2 2021, Hercules generated 100% coverage of our base dividend distribution with NII, delivered sol

Hercules Capital Reports Second Quarter 2021 Financial Results

Hercules Capital Announces Supplemental Cash Distribution of $0.07 Per Share for the Second Quarter Of 2021

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second quarter 2021 cash distribution of $0.32 per share. The following shows the key dates of the second quarter 2021 distr

News for Hercules Capital ETF (HTGC)